. Author manuscript; available in PMC: 2021 Sep 1.

Published in final edited form as: J Rural Health. 2020 Jan 11;36(4):549–563. doi: 10.1111/jrh.12414

Table 2.

Study Sample Characteristics by Posttreatment Communication and Follow-up Care Utilization (N = 90)

					Quality of Patient-Provider Communication					Written Communication					Posttreatment Follow-up

			Overall (n= 90)		High (n = 33)		Not High (n=57)			All (n=34)		Not All (n=56)			3 Months (n= 47)		<3 months (n = 43)

DEMOGRAPHIC FACTORS	Missing (%)		n	%	n	%	n	%	P value	n	%	n	%	P value	n	%	n	%	P value

Age^a	0								.70					.29					.29
≤53 years old			34	38	14	42	20	35		10	29	24	43		21	45	13	30
54-64 years old			30	33	11	33	19	33		14	41	16	29		14	30	16	37
65-83 years old			26	29	8	24	18	32		10	29	16	29		12	26	14	33
Sex	0								.22					.10					.72
Male			16	18	8	24	8	14		9	27	7	13		9	19	7	16
Female			74	82	25	76	49	86		25	74	49	88		38	81	36	84
Race	0								.67					.82					.42
non-Latino White			84	93	30	91	54	95		24	71	42	75		45	96	39	91
Other			6	7	3	9	3	5		10	29	14	25		2	4	4	9
Marital Status	0								.55					.65					.46
Married			66	73	23	70	43	75		24	71	42	75		36	77	30	70
Not married			24	27	10	30	14	25		10	29	14	25		11	23	13	30

SOCIOECONOMIC FACTORS

Education^b	0								.02					.75					.06
<Bachelor’s Degree			45	50	21	64	24	42		16	47	29	52		27	57	18	42
≥Bachelor’s Degree			45	50	12	36	33	58		18	53	27	48		20	43	25	58
Household income^b	7								.04					.01					.11
<$50,001			38	42	19	59	19	37		19	59	19	36		23	52	15	37
≥$50,001			46	51	13	41	33	64		13	41	33	67		21	47	25	63
Private health care insurance	0								.71					.73					.46
Yes			55	61	21	64	34	60		14	41	21	38		27	57	28	65
No			35	39	12	36	23	40		20	59	35	63		20	43	15	35
RURALITY^b	0								.12					.47					.14
Metropolitan (RUCC 1-3)			37	41	17	51	20	35		14	41	23	41		19	44	18	38
Non-metropolitan (RUCC 4-9)			53	59	16	49	37	65		20	59	33	59		24	56	29	61

CANCER-RELATED FACTORS

Cancer sites	7								.94					.91					.18
Breast cancer			31	34	12	38	19	33		11	32	20	36		17	36	14	33
Gynecological			8	9	3	9	5	9		3	9	5	9		3	6	5	12
Digestive			8	9	3	9	5	9		2	6	6	11		3	6	5	12
Skin			9	10	3	9	6	11		3	9	6	11		2	4	7	17
Lymphoma			13	15	3	9	10	18		6	17	7	13		9	19	4	10
Other			20	23	8	25	12	21		9	27	11	20		13	28	7	17

		Range	M		M	SD	M	SD		M	SD	M	SD		M	SD	M	SD

Treatment-related Symptoms	0	0-3.32	0.76		0.63	0.73	0.83	0.87	.28	0.85	0.87	0.70	0.79	.41	1.05	0.88	0.43	0.62	<.001

			n		n	%	n	%	P value	n	%	n	%	P value	n	%	n	%	P value

Time Since Last Treatment	0								.16					.45					.001
<5 years			43	48	19	58	24	42		18	53	25	45		13	30	30	64
5+ years			47	52	14	42	33	58		16	47	31	55		30	70	17	36

OTHER HEALTH FACTORS

Tobacco Use	1								.96					.19					.84
Yes			11	12	4	12	7	13		32	94	46	84		6	13	5	12
No			78	88	29	88	49	88		2	6	9	16		40	87	38	88

		Range	M		M	SD	M	SD		M	SD	M	SD		M	SD	M	SD

Number of lifetime comorbidities	0	0-14	5.77		5	3	6	4	.10	6.32	3.78	5.16	3.27	.13	6.31	3.78	5.16	3.27	.13

Variables presented categorically to facilitate interpretability, but analyzed as continuous variables.

Variables presented categorically to facilitate interpretability, but analyzed as ordinal variables.

Significant associations (P < .05) are in bold. Non-significant associations (P < .10) are italicized.